Xiao-Guo Suo

558 total citations
15 papers, 175 citations indexed

About

Xiao-Guo Suo is a scholar working on Molecular Biology, Nephrology and Cancer Research. According to data from OpenAlex, Xiao-Guo Suo has authored 15 papers receiving a total of 175 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Nephrology and 5 papers in Cancer Research. Recurrent topics in Xiao-Guo Suo's work include Chronic Kidney Disease and Diabetes (3 papers), Porphyrin Metabolism and Disorders (2 papers) and Renal cell carcinoma treatment (2 papers). Xiao-Guo Suo is often cited by papers focused on Chronic Kidney Disease and Diabetes (3 papers), Porphyrin Metabolism and Disorders (2 papers) and Renal cell carcinoma treatment (2 papers). Xiao-Guo Suo collaborates with scholars based in China and Saint Kitts and Nevis. Xiao-Guo Suo's co-authors include Yunyan Du, Xiao‐Ming Meng, Wei‐Jian Ni, Anqi Li, Yang Wang, Hongxing Li, Jiahao Zhang, Qi Sun, Shengli Li and Mingming Liu and has published in prestigious journals such as British Journal of Pharmacology, Biochemical Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Xiao-Guo Suo

15 papers receiving 175 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiao-Guo Suo China	9	110	25	24	19	18	15	175
Mengran Li China	9	92 0.8×	34 1.4×	15 0.6×	45 2.4×	12 0.7×	26	203
Kaifeng Wei China	5	63 0.6×	17 0.7×	22 0.9×	13 0.7×	4 0.2×	8	140
Shimin Jiang China	9	189 1.7×	46 1.8×	29 1.2×	16 0.8×	10 0.6×	18	291
Ying Cao China	10	104 0.9×	41 1.6×	14 0.6×	34 1.8×	13 0.7×	30	274
Sławomir Chrul Poland	8	118 1.1×	32 1.3×	13 0.5×	11 0.6×	14 0.8×	18	312
Hanbin Lin China	11	140 1.3×	21 0.8×	15 0.6×	30 1.6×	33 1.8×	27	309
Yongxiu Huang China	8	162 1.5×	8 0.3×	16 0.7×	20 1.1×	10 0.6×	26	285
Xiaoran Zhu China	6	103 0.9×	22 0.9×	15 0.6×	15 0.8×	5 0.3×	12	177
Jianyong Zhang China	11	130 1.2×	11 0.4×	40 1.7×	21 1.1×	8 0.4×	34	316

Countries citing papers authored by Xiao-Guo Suo

Since Specialization

Citations

This map shows the geographic impact of Xiao-Guo Suo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Guo Suo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Guo Suo more than expected).

Fields of papers citing papers by Xiao-Guo Suo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao-Guo Suo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Guo Suo. The network helps show where Xiao-Guo Suo may publish in the future.

Co-authorship network of co-authors of Xiao-Guo Suo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao-Guo Suo. A scholar is included among the top collaborators of Xiao-Guo Suo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao-Guo Suo. Xiao-Guo Suo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hou, Chao, Xinru Zhang, Jie Wei, et al.. (2025). METTL1-mediated m ⁷ G methylation of Sarm1 mRNA promotes macrophage inflammatory responses and multiple organ injury. Science Immunology. 10(111). eadv4810–eadv4810. 1 indexed citations

Zhu, Sai, Xin Chen, Xiaofeng Li, et al.. (2024). N6-Methyladenosine modification of circDcbld2 in Kupffer cells promotes hepatic fibrosis via targeting miR-144-3p/Et-1 axis. Acta Pharmaceutica Sinica B. 15(1). 296–313. 4 indexed citations

Yao, Rui, et al.. (2024). Pectolinarigenin alleviates calcium oxalate-induced renal inflammation and oxidative stress by binding to HIF-1α. International Immunopharmacology. 143(Pt 1). 113284–113284. 1 indexed citations

Wang, Fang, Xiao-Guo Suo, Jianan Wang, et al.. (2024). SFN promotes renal fibrosis via binding with MYH9 in chronic kidney disease. European Journal of Pharmacology. 979. 176806–176806. 2 indexed citations

He, Xiaoyan, Fang Wang, Xiao-Guo Suo, et al.. (2023). Compound‐42 alleviates acute kidney injury by targeting RIPK3‐mediated necroptosis. British Journal of Pharmacology. 180(20). 2641–2660. 13 indexed citations

Chen, Xin, Sai Zhu, Hai-Di Li, et al.. (2023). N6-methyladenosine-modified circIRF2, identified by YTHDF2, suppresses liver fibrosis via facilitating FOXO3 nuclear translocation. International Journal of Biological Macromolecules. 248. 125811–125811. 21 indexed citations

Wang, Fang, Xiao-Guo Suo, Cong Wang, et al.. (2022). Highly pathogenic coronaviruses and the kidney. Biomedicine & Pharmacotherapy. 156. 113807–113807. 3 indexed citations

Liu, Mingming, Yang Chen, Wei‐Jian Ni, et al.. (2022). Cpd-42 protects against calcium oxalate nephrocalcinosis-induced renal injury and inflammation by targeting RIPK3-mediated necroptosis. Frontiers in Pharmacology. 13. 1041117–1041117. 13 indexed citations

Suo, Xiao-Guo, Fang Wang, Xiaoyan He, et al.. (2022). Targeted inhibition of TGF-β type I receptor by AZ12601011 protects against kidney fibrosis. European Journal of Pharmacology. 929. 175116–175116. 8 indexed citations

10.

He, Yuan, Qin Yang, Chao Li, et al.. (2022). Cpd-0225 attenuates renal fibrosis via inhibiting ALK5. Biochemical Pharmacology. 204. 115240–115240. 3 indexed citations

11.

Wang, Jianan, Xiao-Guo Suo, Xiaoyan He, et al.. (2022). RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation. International Immunopharmacology. 112. 109262–109262. 24 indexed citations

12.

Chen, Xin, Sai Zhu, Siyu Chen, et al.. (2022). miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-β. International Immunopharmacology. 110. 109034–109034. 8 indexed citations

13.

Wang, Fang, Jianan Wang, Xiaoyan He, et al.. (2021). Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis. Acta Pharmacologica Sinica. 43(2). 330–341. 19 indexed citations

14.

Zhang, Jiahao, Hongxing Li, Yunyan Du, et al.. (2021). Anti-inflammatory activity of the water extract of Chloranthus serratus roots in LPS-stimulated RAW264.7 cells mediated by the Nrf2/HO-1, MAPK and NF-κB signaling pathways. Journal of Ethnopharmacology. 271. 113880–113880. 41 indexed citations

15.

Du, Yunyan, et al.. (2019). Water-separated part of Chloranthus serratus alleviates lipopolysaccharide- induced RAW264.7 cell injury mainly by regulating the MAPK and Nrf2/HO-1 inflammatory pathways. BMC Complementary and Alternative Medicine. 19(1). 343–343. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact